Items where Author is "Norouzi-Barough, L."

Article

(2025) Guillain-Barré syndrome (GBS) after severe/critical COVID-19 or COVID-19 vaccination. European Journal of Medical Research. p. 7. ISSN 0949-2321

(2025) A novel ITGB2 variant in a patient with severe recurrent pyoderma gangrenosum-like lesions and underlying leukocyte adhesion deficiency type I: case report and literature review. Archives of Dermatological Research. p. 9. ISSN 0340-3696

(2023) COVID-19-Induced Stroke and the Potential of Using Mesenchymal Stem Cells-Derived Extracellular Vesicles in the Regulation of Neuroinflammation. Cellular and Molecular Neurobiology. pp. 37-46. ISSN 1573-6830 (Electronic) 0272-4340 (Print) 0272-4340 (Linking)

(2022) COVID-19-Induced Stroke and the Potential of Using Mesenchymal Stem Cells-Derived Extracellular Vesicles in the Regulation of Neuroinflammation. Cell Mol Neurobiol. pp. 1-10. ISSN 0272-4340 (Print) 0272-4340

(2022) Fabrication of a biocompatible & biodegradable targeted theranostic nanocomposite with pH-Controlled drug release ability. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY. ISSN 1773-2247 2588-8943 J9 - J DRUG DELIV SCI TEC

(2022) Fabrication of a biocompatible & biodegradable targeted theranostic nanocomposite with pH-Controlled drug release ability. Journal of Drug Delivery Science and Technology. ISSN 17732247 (ISSN)

(2022) Therapeutic potential of mesenchymal stem cell-derived exosomes as a cell-free therapy approach for the treatment of skin, bone, and cartilage defects. Connect Tissue Res. pp. 83-96. ISSN 0300-8207

(2021) Highly sensitive mixed molecular nanostructures of glutamine and doxorubicin on gold for targeted recognition of A2780 cancer cells using impedance spectroscopy and quartz crystal microbalance. Sensors and Actuators, B: Chemical. ISSN 09254005 (ISSN)

(2021) Therapeutic potential of mesenchymal stem cell-derived exosomes as a cell-free therapy approach for the treatment of skin, bone, and cartilage defects. Connect Tissue Res. pp. 1-14. ISSN 0300-8207

(2021) Validation strategies for identifying drug targets in dermal fibrotic disorders. Drug Discov Today. ISSN 1359-6446

(2018) CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line. Iranian Journal of Basic Medical Sciences. pp. 181-187. ISSN 2008-3866

(2018) Molecular mechanisms of drug resistance in ovarian cancer. Journal of Cellular Physiology. pp. 4546-4562. ISSN 0021-9541